Maxime Jullien

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Topics

Acute Myeloid Leukemia

End Stage Renal Disease

Peripheral Blood

Top Venues

American journal of hematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marion Eveillard, Yannick Le Bris, Simon Bouzy, Benoît Tessoulin, Thomas Gastinne, Viviane Dubruille, Cyrille Touzeau, Béatrice Mahé, Nicolas Blin, Anne Lok, Sophie Vantyghem, Clara Sortais, Chloé Antier, Phillipe Moreau, Emmanuel Scotet, Marie C Béné, Patrice Chevallier
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide. American journal of hematology 99 (3) (2024)
Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marion Eveillard, Yannick Le Bris, Simon Bouzy, Benoît Tessoulin, Thomas Gastinne, Viviane Dubruille, Cyrille Touzeau, Béatrice Mahé, Nicolas Blin, Anne Lok, Sophie Vantyghem, Clara Sortais, Chloé Antier, Phillipe Moreau, Emmanuel Scotet, Marie C Béné, Patrice Chevallier
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide. American journal of hematology 99 (3) (2024)
Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marion Eveillard, Yannick Le Bris, Simon Bouzy, Benoît Tessoulin, Thomas Gastinne, Viviane Dubruille, Cyrille Touzeau, Béatrice Mahé, Nicolas Blin, Anne Lok, Sophie Vantyghem, Clara Sortais, Chloé Antier, Phillipe Moreau, Emmanuel Scotet, Marie C Béné, Patrice Chevallier
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide. American journal of hematology 99 (3) (2024)
Cédric De Almeida Braga, Maxence Bauvais, Pierre Sujobert, Mael Heiblig, Maxime Jullien, Baptiste Le Calvez, Camille Richard, Valentin Le Roc'h, Emmanuelle Rault, Olivier Hérault, Pierre Peterlin, Alice Garnier, Patrice Chevallier, Simon Bouzy, Yannick Le Bris, Antoine Néel, Julie Graveleau, Olivier Kosmider, Perrine Paul-Gilloteaux, Nicolas Normand, Marion Eveillard
Deep Learning-Based Blood Abnormalities Detection as a Tool for VEXAS Syndrome Screening. International journal of laboratory hematology (2024)
Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marion Eveillard, Yannick Le Bris, Simon Bouzy, Benoît Tessoulin, Thomas Gastinne, Viviane Dubruille, Cyrille Touzeau, Béatrice Mahé, Nicolas Blin, Anne Lok, Sophie Vantyghem, Clara Sortais, Chloé Antier, Phillipe Moreau, Emmanuel Scotet, Marie C Béné, Patrice Chevallier
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide. American journal of hematology (2024)
Chloé Antier, Maxime Jullien, Benoît Tessoulin, Marion Loirat, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Patrice Chevallier, Thierry Guillaume
Late Relapse after Allogeneic Stem Cell Transplantation in Patients Treated for Acute Myeloid Leukemia: Relapse Incidence, Characteristics, Role of Conditioning Regimen, and Outcome. Cancers 16 (7) (2024)
Chloé Antier, Maxime Jullien, Benoît Tessoulin, Marion Loirat, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Patrice Chevallier, Thierry Guillaume
Late Relapse after Allogeneic Stem Cell Transplantation in Patients Treated for Acute Myeloid Leukemia: Relapse Incidence, Characteristics, Role of Conditioning Regimen, and Outcome. Cancers 16 (7) (2024)
Maxime Jullien, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Thierry Guillaume, Marie Christine Bene, Patrice Chevallier
Addition of ATG to non-myeloablative peripheral blood haploidentical transplant with PTCY decreases acute GVHD rates and improves GVHD-relapse free survival. Bone marrow transplantation (2023)
Béatrice Clémenceau, Amandine Le Bourgeois, Thierry Guillaume, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, Maxime Jullien, Jocelyn Ollier, Audrey Grain, Marie Christine Bene, Patrice Chevallier
Strong SARS-CoV-2 T-Cell Responses after One or Two COVID-19 Vaccine Boosters in Allogeneic Hematopoietic Stem Cell Recipients. Cells 11 (19) (2022)
Béatrice Clémenceau, Thierry Guillaume, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Maxime Jullien, Jocelyn Ollier, Audrey Grain, Marie Christine Bene, Henri Vié, Patrice Chevallier
SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine. Vaccines 10 (3) (2022)
Maxime Jullien, Benoit Tessoulin, Hervé Ghesquières, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Vincent Ribrag, Thierry Lamy, Catherine Thieblemont, Bruno Villemagne, Rémy Gressin, Kamal Bouabdallah, Corinne Haioun, Gandhi Damaj, Luc-Matthieu Fornecker, Jean-Marc Schiano De Colella, Pierre Feugier, Olivier Hermine, Guillaume Cartron, Christophe Bonnet, Marc André, Clement Bailly, René-Olivier Casasnovas, Steven Le Gouill
Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years. Cancers 13 (18) (2021)
Amandine Le Bourgeois, Marianne Coste-Burel, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Berthe-Marie Imbert, Thomas Drumel, Beatrice Mahé, Viviane Dubruille, Nicolas Blin, Anne Lok, Cyrille Touzeau, Thomas Gastinne, Benoît Tessoulin, Maxime Jullien, Sophie Vantyghem, Phillipe Moreau, Steven Le Gouill, Marie Christine Bene, Patrice Chevallier
Interest of a third dose of BNT162b2 anti-SARS-CoV-2 messenger RNA vaccine after allotransplant. British journal of haematology (2021)
Dhon Roméo Makanga, Maxime Jullien, Gaëlle David, Nolwenn Legrand, Catherine Willem, Léa Dubreuil, Alexandre Walencik, Cyrille Touzeau, Thomas Gastinne, Benoit Tessoulin, Steven Le Gouill, Béatrice Mahé, Katia Gagne, Patrice Chevallier, Béatrice Clemenceau, Christelle Retiere
Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response. Oncoimmunology 10 (1) (2021)
Thomas Gastinne, Amandine Le Bourgeois, Marianne Coste-Burel, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Berthe-Marie Imbert, Thomas Drumel, Beatrice Mahe, Viviane Dubruille, Nicolas Blin, Anne Lok, Cyrille Touzeau, Benoît Tessoulin, Maxime Jullien, Sophie Vanthygem, Marie Christine Bene, Phillipe Moreau, Steven Le Gouill, Patrice Chevallier
Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy. British journal of haematology (2021)
Maxime Jullien, Corentin Orvain, Ana Berceanu, Marie-Anne Couturier, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Marion Klemencie, Aline Schmidt, Mathilde Hunault, Etienne Daguindau, Xavier Roussel, Pascal Delepine, Gaelle Guillerm, Aurelien Giltat, Sylvie François, Sylvain Thepot, Steven Le Gouill, Marie-C Béné, Patrice Chevallier
Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post-transplant cyclophosphamide. Cancer medicine 10 (20) (2021)
Pierre Peterlin, Thomas Cluzeau, Maxime Jullien, Anne-Marie Ngo Nloga, Anne Calleja, Eurydice Angeli, Patrice Chevallier, Thierry Guillaume, Alice Garnier, Amandine Le Bourgeois, Steven Le Gouill, Pierre Fenaux, Lionel Adès, Cécile Bally
Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients. British journal of haematology 190 (3) (2020)
Maxime Jullien, Cyrille Touzeau, Philippe Moreau
Monoclonal antibodies as an addition to current myeloma therapy strategies. Expert review of anticancer therapy 21 (1) (2020)